Kamal Sweidan

Kamal Sweidan


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2020 in Current Topics in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
DSDima A. Sabbah
Dima A. Sabbah
RHRima Hajjo
Rima Hajjo
KSKamal Sweidan
Kamal Sweidan
The epidermal growth factor receptor (EGFR) belongs to the ERBB family of tyrosine kinase receptors. EGFR signaling cascade is a key regulator in cell proliferation, differentiation, division, survival, and cancer development. In this review, the EGFR structure and its mutations, signaling pathway, ligand binding and EGFR dimerization, EGF/EGFR interaction, and the progress in the development of EGFR inhibitors have been explored.

21 September 2020 in Molecules
Verified
Journal Article
Open access
PDF file
HSHaythem A. Saadeh
Haythem A. Saadeh
KSKamal Sweidan
Kamal Sweidan
Mohammad MubarakMohammad Mubarak
Mohammad Mubarak
Compounds containing the 8-hydroxyquinoline (8-HQ) 1 nucleus exhibit a wide range of biological activities, including antimicrobial, anticancer, and antifungal effects. The chemistry and biology of this group have attracted the attention of chemists, medicinal chemists, and professionals in health sciences. A number of prescribed drugs incorporate this group, and numerous 8-HQ- based molecules can be used to develop potent lead compounds with good efficacy and low toxicity. This review focusses on the recent advances in the synthesis of 8-HQ derivatives with different pharmacological properties, including anticancer, antiviral, and antibacterial activities. For this purpose, recent relevant references were searched in different known databases and search engines, such as MEDLINE (PubMed), Google Scholar, Science Direct, Scopus, Cochrane, Scientific Information Database (SID), SciFinder, and Institute for Scientific Information (ISI) Web of Knowledge. This review article provides a literature overview of the various synthetic strategies and biological activities of 8-HQ derivatives and covers the recent related literature. Taken together, compounds containing the 8-HQ moiety have huge therapeutic value and can act as potential building blocks for various pharmacologically active scaffolds. In addition, several described compounds in this review could act leads for the development of drugs against numerous diseases including cancer.

1 June 2016 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
KSKamal Sweidan
Kamal Sweidan
DSDima Sabbah
Dima Sabbah
SBSanaa Bardaweel
Sanaa Bardaweel
KDKhadeja Abu Dush
Khadeja Abu Dush
GSGhassan Abu Sheikha
Ghassan Abu Sheikha
Mohammad MubarakMohammad Mubarak
Mohammad Mubarak

30 March 2022 in Inorganics
Verified
Journal Article
Open access
PDF file
Mahmoud Shaker SunjukMahmoud Shaker Sunjuk
Mahmoud Shaker Sunjuk
Lana Mohmmad Saeed Al-NajjarLana Mohmmad Saeed Al-Najjar
Lana Mohmmad Saeed Al-Najjar
MSMajed Shtaiwi
Majed Shtaiwi
BEBassam EL-ESWED
Bassam EL-ESWED
MAMousa Al-Noaimi
Mousa Al-Noaimi
KSKamal Sweidan
Kamal Sweidan
Schiff bases have played significant roles in the development of inorganic or coordination chemistry. Three Schiff base (NB, CB and HB) ligands, prepared for the reaction of 2-amino-6-methoxy-benzothiazole with 2-Nitrobenzaldehyde, 2-chlorobenzaldehyde and 2,4-Dihydroxybenzaldehyed, respectively, were investigated for their transition metal complexes, which were prepared by reacting the ligand (2:1 molar ratio) with Co(II), Ni(II), Cu(II), Cd(II), Cr(III) and Fe(III) chlorides. The nature of the interaction between the metal ions and ligands (L) was studied with the aid of magnetic susceptibility, elemental analysis, FTIR and 1H-NMR spectroscopy. Based on the magnetic superstability and elemental analysis results, octahedral structures of the complexes, such as [ML2Cl2] or [ML2Cl(OH)], were proposed for Cu(II), Cd(II), Co(II) and Ni(II) in which the ligand (L:NB, CB or HB) is bidentate through the azomethine and benzothiazole nitrogen. For Cr(III) and Fe(III) complexes, octahedral ML2Cl(OH)2 or ML2(OH)3 structures were proposed, where one ligand is monodentate and the other is bidentate. The azomethine ν(-HC=N-) and 1H-NMR peaks of NB and CB were shifted to a higher frequency and downfield, respectively, upon complexation with metal ions. The bonding of OH groups of HB to Co(II), Cu(II) and Ni(II) enables π-backdonation from these metals to the azomethine of Schiff bases and the consequent shift of ν(-HC=N-) to a lower frequency and changes in the intensity of the 1H-NMR peak of OH. On the other hand, this backdonation was not evidenced in the FTIR of HB complexes with high-charge Cr(III) and Fe(III) ions.

19 April 2018 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
DSDima A. Sabbah
Dima A. Sabbah
BHBayan Hishmah
Bayan Hishmah
KSKamal Sweidan
Kamal Sweidan
SBSanaa Bardaweel
Sanaa Bardaweel
MAMurad AlDamen
Murad AlDamen
Mohammad MubarakMohammad Mubarak
Mohammad Mubarak
Background: Oncogenic potential of phosphatidylinositol 3-kinase (PI3Kα) has been highlighted as a therapeutic target for anticancer drug design. Objective: Target compounds were designed to address the effect of different substitution patterns at the N atom of the carboxamide moiety on the bioactivity of this series. Methods: Synthesis of the targeted compounds, crystallography, biological evaluation tests against human colon carcinoma (HCT-116), and Glide docking studies. Results: A new series of N-substituted- 4-hydroxy-2-quinolone-3-carboxamides was prepared and characterized by means of FT-IR, 1H and 13C NMR, and elemental analysis. In addition, the identity of the core nucleus 5 was successfully characterized with the aid of X-ray crystallography. Biological activity of prepared compounds was investigated in vitro against human colon carcinoma (HCT-116) cell line. Results revealed that these compounds inhibit cell proliferation and induce apoptosis through an increase in caspase-3 activity and a decrease in DNA cellular content. Compounds 7, 14, and 17 which have H-bond acceptor moiety on p-position displayed promising PI3Kα inhibitory activity. On the other hand, derivatives tailored with bulky and hydrophobic motifs (16 and 18) on o- and m-positions exhibited moderate activity. Molecular docking studies against PI3Kα and caspase-3 showed an agreement between the predicted binding affinity (ΔGobsd) and IC50 values of the derivatives for the caspase-3 model. Furthermore, Glide docking studies against PI3Kα demonstrated that the newly synthesized compounds accommodate PI3Kα kinase catalytic domain and form H-bonding with key binding residues. Conclusion: The series exhibited a potential PI3Kα inhibitory activity in HCT-116 cell line.

30 April 2022 in Molecules
Verified
Journal Article
Open access
PDF file
SBSanaa Bardaweel
Sanaa Bardaweel
RAreem aljanabi
reem aljanabi
DSDima Sabbah
Dima Sabbah
KSKamal Sweidan
Kamal Sweidan
Lung cancer is one of the most common causes of cancer-related deaths worldwide. Monoamine Oxidase-A (MAO-A) enzyme mediates the production of reactive oxygen species (ROS) that trigger DNA damage and oxidative injury of cells resulting in tumor initiation and progression. Available MAO-A inhibitors are used as antidepressants, however, their role as anticancer agents is still under investigation. Ligand- and structure-based drug design approaches guided the discovery and development of novel MAO-A inhibitors. A series of 1H indole-2-carboxamide derivatives was prepared and characterized using 1H-NMR, 13C-NMR, and IR. The antiproliferative effects of MAO-A inhibitors were evaluated using the cell viability assay (MTT), and MAO-A activity was evaluated using MAO-A activity assay. The presumed inhibitors significantly inhibited the growth of lung cell lines in a dose- and time dependent manner. The half maximal inhibitory concentration (IC50) values of MAO-A inhibitors (S1, S2, S4, S7, and S10) were 33.37, 146.1, 208.99, 307.7, and 147.2 µM, respectively, in A549. Glide docking against MAO-A showed that the derivatives accommodate MAO-A binding cleft and engage with key binding residues. MAO-A inhibitors provide significant and consistent evidence on MAO-A activity in lung cancer and present a potential target for the development of new chemotherapeutic agents.